Evolus Inc (EVL.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
At close: 09:52PM CET
| Previous close | 8.95 |
| Open | 8.95 |
| Bid | 8.60 x 0 |
| Ask | 9.10 x 0 |
| Day's range | 8.85 - 9.15 |
| 52-week range | 6.15 - 13.80 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 01 Mar 2023 - 06 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Evolus to Participate in the SVB Securities Global Biopharma Conference
NEWPORT BEACH, Calif., January 31, 2023--Evolus announces that members of its management team will be participating in the SVB Securities Global Biopharma Conference.
- Simply Wall St.
Institutional investors own a significant stake of 39% in Evolus, Inc. (NASDAQ:EOLS)
To get a sense of who is truly in control of Evolus, Inc. ( NASDAQ:EOLS ), it is important to understand the ownership...
- Business Wire
"Extra-Strength" Formulation of Jeuveau® Demonstrates Effects Lasting 26 Weeks in Interim Phase II Data Results, Representing Prolonged 6-Month Performance
NEWPORT BEACH, Calif., January 28, 2023--Evolus presents interim data from its Phase II clinical study at the 2023 IMCAS World Congress in Paris.
© 2023 Yahoo. All rights reserved.
